Inhibitors of Cyclin-Dependent Kinases: Types and Their Mechanism of Action

Recent studies on cyclin-dependent kinase (CDK) inhibitors have revealed that small molecule drugs have become very attractive for the treatment of cancer and neurodegenerative disorders. Most CDK inhibitors have been developed to target the ATP binding pocket. However, CDK kinases possess a very si...

Descripción completa

Detalles Bibliográficos
Autores principales: Łukasik, Paweł, Baranowska-Bosiacka, Irena, Kulczycka, Katarzyna, Gutowska, Izabela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001317/
https://www.ncbi.nlm.nih.gov/pubmed/33802080
http://dx.doi.org/10.3390/ijms22062806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001317/
https://www.ncbi.nlm.nih.gov/pubmed/33802080
http://dx.doi.org/10.3390/ijms22062806

Ejemplares similares